Blockade of Influenza A virus (A/England/195/2009(H1N1)) full length M2 S31N mutant expressed in HEK cells at 100 uM after 3 mins by voltage clamp technique
Blockade of Influenza A virus (A/England/195/2009(H1N1)) full length M2 S31N mutant expressed in HEK cells at 100 uM after 30 mins by voltage clamp technique
Blockade of Influenza A virus (A/England/195/2009(H1N1)) full length M2 proton channel expressed in HEK cells at 10 uM after 3 mins by voltage clamp technique
Antiviral activity against Influenza A virus (A/California/07/2009(H1N1)) infected in MDCK cells expressing M2 S31N mutant after overnight incubation by fluorescence-based miniplaque assay
Antiviral activity against Influenza A virus (A/Puerto Rico/8/34(H1N1)) infected in MDCK cells expressing M2 V27T/S31N mutant after overnight incubation by fluorescence-based miniplaque assay
Antiviral activity against Influenza A virus A/WS/33(H1N1) infected in MDCK cells expressing M2 S31N mutant after overnight incubation by fluorescence-based miniplaque assay
Antiviral activity against Influenza A virus A2/Taiwan/1/64(H2N2) infected in MDCK cells expressing wild type M2 after overnight incubation by fluorescence-based miniplaque assay
Antiviral activity against Influenza A virus A/Victoria/3/75(H3N2) infected in MDCK cells expressing wild type M2 after overnight incubation by fluorescence-based miniplaque assay
Antiviral activity against Influenza A virus (A/Hong Kong/1/1968(H3N2)) infected in MDCK cells expressing M2 A30T mutant at 5 ug/ml after 2 to 10 passages measured after 3 to 4 days
Antiviral activity against Influenza A virus (A/California/07/2009(H1N1)) infected in MDCK cells treated with 5 uM of compound measured after 1 passage by fluorescence-based miniplaque assay
Antiviral activity against Influenza A virus (A/California/07/2009(H1N1)) infected in MDCK cells treated with 5 uM of compound measured after 2 passages by fluorescence-based miniplaque assay
Antiviral activity against Influenza A virus (A/California/07/2009(H1N1)) infected in MDCK cells treated with 5 uM of compound measured after 5 passages by fluorescence-based miniplaque assay
Antiviral activity against Influenza A virus (A/California/07/2009(H1N1)) infected in MDCK cells treated with 5 uM of compound measured after 8 passages by fluorescence-based miniplaque assay
Antiviral activity against Influenza A virus (A/California/07/2009(H1N1)) infected in MDCK cells treated with 5 uM of compound measured after 10 passages by fluorescence-based miniplaque assay
Antiviral activity against Influenza A virus (A/California/07/2009(H1N1)) infected in MDCK cells treated with 5 uM of compound measured after 12 passages by fluorescence-based miniplaque assay
Antiviral activity against Influenza A virus (A/California/07/2009(H1N1)) infected in MDCK cells measured after 10 passages by fluorescence-based miniplaque assay
Antiviral activity against Influenza A virus (A/California/07/2009(H1N1)) infected in MDCK cells measured after 30 passages by fluorescence-based miniplaque assay